학술논문
Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II Study.
Document Type
journal article
Author
Source
Journal of Clinical Oncology; 12/21/2021 Supplement, Vol. 39, pJCO2102067-JCO2102067, 1p
Subject
Language
ISSN
0732183X